UOC
NGNE icon

UBS O'Connor’s Neurogene NGNE Stock Holding History

UBS O'Connor’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,761
Closed -$520K – 393
2025
Q2 		$520K Sell
34,761
-21,254
-38% -$334K 0.01% 270
2025
Q1 		$656K Buy
56,015
+23,281
+71% +$404K 0.02% 211
2024
Q4 		$748K Buy
32,734
+23,907
+271% +$890K 0.02% 254
2024
Q3 		$370K Buy
8,827
+1,727
+24% +$67K 0.01% 362
2024
Q2 		$258K Buy
+7,100
New +$250K 0.01% 408

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return